Intuitive Surgical faces continued challenges in Asia. The company's Ion system replacements are also declining, with lower da Vinci procedure volume growth projected for 2026. However, the value of ...

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 8 Best Healthcare AI Stocks to Buy According to Analysts. On April 23, ...

The maker of surgical robots is grappling with concerns about competition.

On Tuesday, Intuitive Surgical, Inc. (NASDAQ:ISRG) announced plans to acquire the da Vinci and Ion distribution businesses in Italy, Spain, Portugal, Malta, San Marino, and associated territories. The ...

Intuitive Surgical, maker of the da Vinci and Ion systems, beat third-quarter profit and sales forecasts. That lifted the shares into the plus column for 2025. The company is "in the driver’s seat" of ...

Earlier this year, Intuitive Surgical warned that supplies may be tight in the months ahead as it continues to roll out the latest iteration of its da Vinci robot. And, while the company has made some ...

Intuitive Surgical, Inc. ISRG is well-poised for growth in the coming quarters, courtesy of its strength in robotics. The optimism, led by solid results in the last few quarters and its progress on ...

The surgical robotics company's procedure growth remained impressive, supporting recurring revenue. Intuitive Surgical's Da Vinci 5 adoption is ramping quickly. Sales of Ion are growing faster than ...

2026 hasn't been a happy New Year so far for Intuitive Surgical (NASDAQ: ISRG) shareholders. The robotic surgical systems stock is in negative territory. And Intuitive's latest quarterly results ...